-
A New Consensus of BC Treatment (Including New Immune Checkpoint Inhibitors)
A recent (2017) small group consensus document by many of the major, well-known leaders in the treatment and research of bladder cancer.
A couple of small surprises are found in this document, where the consensus is somewhat different from those expressed by the larger membership organizations’ consensus documents.
Practical, with a view to emerging treatments for BC.
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Article (PDF Available) • December 2017
Ashish M. Kamat1*, Joaquim Bellmunt2, Matthew D. Galsky3, Badrinath R. Konety4, Donald L. Lamm5,David Langham6, Cheryl T. Lee7, Matthew I. Milowsky8, Michael A. O’Donnell9, Peter H. O’Donnell10,Daniel P. Petrylak11, Padmanee Sharma12, Eila C. Skinner13, Guru Sonpavde14, John A. Taylor III15,Prasanth Abraham16and Jonathan E. Rosenberg1PDF Download Available). Available from:
Best to all,
Jack
6/2015 HG Papillary & CIS
3 Years and 30 BCG/BCG+Inf
Tis CIS comes back.
BC clear as of 5/17 !
RCC found in my one & only kidney 10/17
Begin Chemo; Cisplatin and Gemzar
8/18 begin Chemo# 3
Begin year 4 with cis
2/19 Chemo #4
9/19 NED again :)
1/2020 CIS is back
Tried Keytruda, stopped by side effects
Workin on a new plan for 2021 -
1 Reply
-
Very interesting review, Jack. Thanks for citing it for us.
Sara Anne
Diagnosis 2-08 Small papillary TCC; CIS
BCG; BCG maintenance
Vice-President, American Bladder Cancer Society
Forum Moderator
Log in to reply.